Aurrigo hits the fairway with completion of Canada’s first ever public autonomous pod trial

A Midlands-based driverless vehicle specialist has completed its first ever ‘public’ autonomous trial in Canada, opening up new opportunities for expansion in North America.

Aurrigo has joined forces with the Ottawa L5 powered by Invest Ottawa and the Kanata North Business Association to give more than 350 local people the opportunity to ride in two of its Pod Zero autonomous vehicles at the Marches Golf Club in Ottawa.

Over the course of three days, community members have travelled across a complex route that includes hills, a tunnel, narrow tree covered bridges and many twists and turns.

The UK-based first and last mile transport solution specialist worked with local technology companies to create a safe environment for the pods. Feedback from the trial is now being collated by Aurrigo and Transport Canada to enhance user experience and support continued Connected & Autonomous Vehicle policy research.

David Keene, CEO of Aurrigo, commented: “Ottawa L5 was one of the early adopters of our Pod Zero technology and, over the last 18 months, we have developed a strategic relationship that truly leverages our respective strengths.

“The trial at Marches Golf Club in Ottawa is the first public trial we have completed in Canada and the response was fantastic with all the ride places filled and plenty of user comments on how we can refine our autonomous offer even further.

“Our pods represent impactful first and last mile transport solutions with deployment opportunities in a commercial, leisure, education or retail environment. There’s a really strong supply chain in Ottawa that can help support our roll-out in this area and other Canadian cities.”

Ottawa L5’s Ride the Pod trial, which was supported by KRP Properties and the Brookstreet Hotel, had a strong focus on safety, with the Aurrigo engineering team contributing to the pilot project design, testing/implementation and overseeing the operation of the Pod Zero.

The Canadian trial comes just a few weeks after Aurrigo announced £1.5m of new orders from across the world.

This growth takes its annual sales up to £4.2m and, with a strong pipeline of future orders in place, the company is predicting a further £6m of contracts between now and the end of 2020.